FCER2 Antikörper (PE)
-
- Target Alle FCER2 Antikörper anzeigen
- FCER2 (Fc Fragment of IgE, Low Affinity II, Receptor For (CD23) (FCER2))
-
Reaktivität
- Maus
-
Wirt
- Ratte
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser FCER2 Antikörper ist konjugiert mit PE
-
Applikation
- Flow Cytometry (FACS)
- Klon
- B3B4
- Isotyp
- IgG2a, kappa
- Top Product
- Discover our top product FCER2 Primärantikörper
-
-
- Applikationshinweise
- Check your vial before the experiment. Since applications vary, the appropriate dilutions must be determined for individual use. We suggest each investigator should titrate the reagent to obtain optimal results [The recommended concentration is 0.1-1 μg/10^6 cells in 100 μL volume].
- Kommentare
-
Matching Isotype Control: PE Rat IgG2a, κ Isotype Control[2A3] (ABIN7469840)
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 0.2 mg/mL
- Buffer
- PBS with 0.05 % Proclin300, 1 % BSA
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C
- Informationen zur Lagerung
- Store at 2~8°C and protected from prolonged exposure to light. Do not freeze.
-
- Target
- FCER2 (Fc Fragment of IgE, Low Affinity II, Receptor For (CD23) (FCER2))
- Andere Bezeichnung
- CD23 (FCER2 Produkte)
- Synonyme
- BLAST-2 antikoerper, CD23 antikoerper, CD23A antikoerper, CLEC4J antikoerper, FCE2 antikoerper, IGEBF antikoerper, Fcer2a antikoerper, Fc fragment of IgE receptor II antikoerper, FCER2 antikoerper, Fcer2 antikoerper
- Hintergrund
- Fcer2,Fcer2a,Lymphocyte IgE receptor,Fc-epsilon-RII,CD23 is a 45 kD protein also known as low affinity IgE Fc receptor, FcεRII, BLAST-2, Ly-42, or B6. It is a member of the Ig family, expressed on conventional B (but not B-1) cells and follicular dendritic cells. CD23 responds to high levels of IgE by downregulating IgE secretion.
- Gen-ID
- 14128
- UniProt
- P20693
- Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
-